Treatment of Relapsed/Refractory CLL/SLL

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Cancer Conversations: BTK Inhibitor Therapies for CLL/SLL and MCL in 2022

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
Podcast Pearls: Expert Answers to Key Questions on Current and Emerging BTK Inhibitor Therapies for CLL and MCL

Content Format:

PDF

Credit Type:

--

Credits:

--
Addressing Evolving Educational Needs on BTK Inhibitor Therapies in CLL/SLL and MCL

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.00
Expert Answers to Key Questions on Current and Emerging BTK Inhibitor Therapies for CLL and MCL

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
BTK Inhibitor Therapies in CLL/SLL and MCL

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
ExpressPoints: BTK Inhibitor Therapies in CLL/SLL and MCL

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Mastering Current Management of CLL

Content Format:

Multimedia

Credit Type:

ACPE

Credits:

1.00
Answers to Frequently Asked Questions on Optimizing CLL Management With BTK Inhibitors

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
ExpressPoints Mastering Current Management of CLL

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Overview of CLL/SLL Treatment Landscape: Mastering Treatments and Special Considerations in CLL/SLL

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Interactive Decision Support Tool: Expert Treatment Recommendations for Patients With Newly Diagnosed or Relapsed/Refractory Follicular Lymphoma

Content Format:

Tool

Credit Type:

--

Credits:

--
An Expert’s Guide to ASH 2020: A Preview of the Top Abstracts

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Cases in CLL: Third-line Treatment Following BTK Inhibitor– and Venetoclax-Based Therapy

Content Format:

Multimedia

Credit Type:

AANP | ACPE | AMA

Credits:

0.25
ExpressPoints: Critical Advances in the Management of Follicular Lymphoma

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Cases in CLL: Options for an Older Patient Requiring First-line Therapy

Content Format:

Multimedia

Credit Type:

AANP | ACPE | AMA

Credits:

0.25
Cases in CLL: Patient Progressing on BR With Subsequent Ibrutinib Intolerance

Content Format:

Multimedia

Credit Type:

AANP | ACPE | AMA

Credits:

0.25
Cases in CLL Slides: Patient Progressing on BR With Subsequent Ibrutinib Intolerance

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Cases in CLL: High-Risk Patient Requiring First-line Therapy

Content Format:

Multimedia

Credit Type:

AANP | ACPE | AMA

Credits:

0.25
Cases in CLL: Fit, Younger Patient Requiring First-line Therapy

Content Format:

Multimedia

Credit Type:

AANP | ACPE | AMA

Credits:

0.25
Cases in CLL: Second-Line Therapy Following Chemoimmunotherapy

Content Format:

Multimedia

Credit Type:

AANP | ACPE | AMA

Credits:

0.25
Cases in CLL Slides: Fit, Younger Patient Requiring First-line Therapy

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Overcoming BTK Resistance in CLL With Noncovalent BTK Inhibitors—Where We Are

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 1

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 3

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 2

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors

Content Format:

Video

Credit Type:

AMA

Credits:

1.50
ExpressPoints Chronic Lymphocytic Leukemia: New Horizons with BTK Inhibitors

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Hot Off the Press: New Data on the Use of Acalabrutinib to Manage Patients With Severe COVID-19

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Overview of the BCR Pathway and BTK in Tumor Development

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
BTK Inhibitors: Future Directions

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
New Insights in Hematologic Malignancies and Disorders: Independent Conference Coverage of the 2019 ASH Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
Expert View on Managing Patients With CLL Using Targeted Therapies

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Expert View on Managing Patients With CLL Using Targeted Therapies

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
My Take on Key Studies in CLL and Lymphomas From ASH 2019

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Preview of ASH 2019: Key Expert-Selected Studies

Content Format:

Clinical Thought

Credit Type:

AMA

Credits:

1.00
Practical Guidance on Optimizing CLL Care in the Era of Molecular Therapies

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Preview of Hot Topics at ASH 2018: Key Expert-Selected Studies

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--